{"id":43811,"date":"2022-06-21T17:49:57","date_gmt":"2022-06-21T15:49:57","guid":{"rendered":"https:\/\/miranza.es\/uncategorized\/especialistas-de-miranza-y-de-la-universidad-de-harvard-estudian-futuras-terapias-para-la-retina\/"},"modified":"2024-10-30T16:18:37","modified_gmt":"2024-10-30T15:18:37","slug":"miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies","status":"publish","type":"post","link":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/","title":{"rendered":"Miranza Specialists and Harvard University Study Future Treatments for Serious Retinal Pathologies"},"content":{"rendered":"\n<p>Experts from<strong> <\/strong><a href=\"https:\/\/miranza.es\/\">Miranza<\/a> are partnering with Harvard University\u2019s <em>Schepens Eye Research Institute<\/em> (Boston, USA) on several scientific projects that seek to respond to some of the most serious ophthalmic conditions today. Specifically, they are analysing the anomalous growth of blood vessels (neovascularisation) and scarring processes that lead to blindness in different eye diseases. Their preliminary scientific conclusions have already been published in benchmark journals, such as <em>Nature Scientific Reports<\/em>, <em>American Journal of Pathology <\/em>and <em>Ophthalmology Science<\/em>.\u00a0<\/p>\n\n\n\n<p>The team of experts, comprising <strong>Dr Luc\u00eda Gonz\u00e1lez<\/strong>, a specialist in retinal and macular pathologies at IMO Grupo Miranza in Madrid, <strong>Dr Santiago Delgado<\/strong>, a cornea and cataract specialist from Miranza Madrid and <a href=\"https:\/\/miranza.es\/en\/our-team\/ophthalmological-specialists\/jose-maria-ruiz-moreno-en\/\"><strong>Dr Jose Mar\u00eda Ruiz Moreno<\/strong><\/a>, a vitreoretinal surgeon from IMO Grupo Miranza in Madrid, are studying the role of a new therapeutic target, the RUNX1 protein, as an important mediator of neovascularisation and ocular fibrosis. The specialists are looking into inhibiting the protein as a potential treatment for diseases, such as neovascularisation and corneal fibrosis, age-related macular degeneration (AMD), diabetic retinopathy and proliferative vitreoretinopathy.<\/p>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-2 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"900\" height=\"600\" data-id=\"43762\" src=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Santiago-Delgado.jpg\" alt=\"\" class=\"wp-image-43762\" srcset=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Santiago-Delgado.jpg 900w, https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Santiago-Delgado-300x200.jpg 300w, https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Santiago-Delgado-768x512.jpg 768w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"900\" height=\"675\" data-id=\"43764\" src=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Ruiz-Moreno.jpg\" alt=\"\" class=\"wp-image-43764\" srcset=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Ruiz-Moreno.jpg 900w, https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Ruiz-Moreno-300x225.jpg 300w, https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Ruiz-Moreno-768x576.jpg 768w\" sizes=\"auto, (max-width: 900px) 100vw, 900px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"900\" data-id=\"43766\" src=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Lucia-Gonzalez.jpg\" alt=\"\" class=\"wp-image-43766\" srcset=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Lucia-Gonzalez.jpg 600w, https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/Lucia-Gonzalez-200x300.jpg 200w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n<\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Drops instead of injections in the eye to treat eye pathologies<\/strong><\/h2>\n\n\n\n<p>The research team has also successfully formulated the RUNX1 inhibitor as a nanoemulsion, enabling its application as drops. This could allow many patients with eye diseases to do without eye injections and instead apply the eye drop treatment, thus significantly improving their quality of life.<\/p>\n\n\n\n<p>The research by this multidisciplinary team has been presented in different lectures at Harvard University and at international congresses to promote these advances, which have already been published in leading scientific journals, such as <strong><em>Nature Scientific Reports, American Journal of Pathology <\/em><\/strong>and<strong><em> Ophthalmology Science<\/em><\/strong>, among others.&nbsp;<\/p>\n\n\n\n<p>The aim of these works is to research and develop future therapies that can improve patient vision and quality of life.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Experts from Miranza are partnering with Harvard University\u2019s Schepens Eye Research Institute (Boston, USA) on several scientific projects that seek to respond to some of the most serious ophthalmic conditions today. Specifically, they are analysing the anomalous growth of blood vessels (neovascularisation) and scarring processes that lead to blindness in different eye diseases. Their preliminary [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":43832,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[4],"tags":[264,265,266,267,268,269],"class_list":["post-43811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-fibrosis-ocular-en","tag-imo-grupo-miranza-en","tag-inyecciones-intraoculares-en","tag-miranza-madrid-en","tag-neovascularizacion-en","tag-retina-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Study of treatments for retinal pathologies | Miranza<\/title>\n<meta name=\"description\" content=\"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Study of treatments for retinal pathologies | Miranza\" \/>\n<meta property=\"og:description\" content=\"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/\" \/>\n<meta property=\"og:site_name\" content=\"Miranza\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/GrupoMiranza\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-21T15:49:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-30T15:18:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Equipo Miranza\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GrupoMiranza\" \/>\n<meta name=\"twitter:site\" content=\"@GrupoMiranza\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Equipo Miranza\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/\"},\"author\":{\"name\":\"Equipo Miranza\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#\\\/schema\\\/person\\\/e01c042f39bcd4da7bc9b77d6e23bf76\"},\"headline\":\"Miranza Specialists and Harvard University Study Future Treatments for Serious Retinal Pathologies\",\"datePublished\":\"2022-06-21T15:49:57+00:00\",\"dateModified\":\"2024-10-30T15:18:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/\"},\"wordCount\":313,\"publisher\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/miranza_doctores.jpg\",\"keywords\":[\"fibrosis ocular\",\"IMO Grupo Miranza\",\"inyecciones intraoculares\",\"Miranza Madrid\",\"neovascularizaci\u00f3n\",\"retina\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/\",\"url\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/\",\"name\":\"Study of treatments for retinal pathologies | Miranza\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/miranza_doctores.jpg\",\"datePublished\":\"2022-06-21T15:49:57+00:00\",\"dateModified\":\"2024-10-30T15:18:37+00:00\",\"description\":\"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/miranza_doctores.jpg\",\"contentUrl\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/miranza_doctores.jpg\",\"width\":740,\"height\":600,\"caption\":\"miranza_doctores\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/news\\\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/miranza.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/miranza.es\\\/en\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Miranza Specialists and Harvard University Study Future Treatments for Serious Retinal Pathologies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/miranza.es\\\/en\\\/\",\"name\":\"Miranza\",\"description\":\"Somos tus centros de excelencia, especialistas en bienestar ocular. Estamos a tu lado, creando nuevos horizontes para seguir viendo.\",\"publisher\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/miranza.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#organization\",\"name\":\"Miranza\",\"url\":\"https:\\\/\\\/miranza.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/logo-miranza.jpg\",\"contentUrl\":\"https:\\\/\\\/miranza.es\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/logo-miranza.jpg\",\"width\":600,\"height\":600,\"caption\":\"Miranza\"},\"image\":{\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/GrupoMiranza\\\/\",\"https:\\\/\\\/x.com\\\/GrupoMiranza\",\"https:\\\/\\\/www.instagram.com\\\/grupomiranza\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/grupomiranza\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCX2gEI-gOFCbPHZ7QSTkLYQ\\\/featured\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/miranza.es\\\/en\\\/#\\\/schema\\\/person\\\/e01c042f39bcd4da7bc9b77d6e23bf76\",\"name\":\"Equipo Miranza\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g\",\"caption\":\"Equipo Miranza\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Study of treatments for retinal pathologies | Miranza","description":"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/","og_locale":"en_US","og_type":"article","og_title":"Study of treatments for retinal pathologies | Miranza","og_description":"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.","og_url":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/","og_site_name":"Miranza","article_publisher":"https:\/\/www.facebook.com\/GrupoMiranza\/","article_published_time":"2022-06-21T15:49:57+00:00","article_modified_time":"2024-10-30T15:18:37+00:00","og_image":[{"width":740,"height":600,"url":"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg","type":"image\/jpeg"}],"author":"Equipo Miranza","twitter_card":"summary_large_image","twitter_creator":"@GrupoMiranza","twitter_site":"@GrupoMiranza","twitter_misc":{"Written by":"Equipo Miranza","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#article","isPartOf":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/"},"author":{"name":"Equipo Miranza","@id":"https:\/\/miranza.es\/en\/#\/schema\/person\/e01c042f39bcd4da7bc9b77d6e23bf76"},"headline":"Miranza Specialists and Harvard University Study Future Treatments for Serious Retinal Pathologies","datePublished":"2022-06-21T15:49:57+00:00","dateModified":"2024-10-30T15:18:37+00:00","mainEntityOfPage":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/"},"wordCount":313,"publisher":{"@id":"https:\/\/miranza.es\/en\/#organization"},"image":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#primaryimage"},"thumbnailUrl":"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg","keywords":["fibrosis ocular","IMO Grupo Miranza","inyecciones intraoculares","Miranza Madrid","neovascularizaci\u00f3n","retina"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/","url":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/","name":"Study of treatments for retinal pathologies | Miranza","isPartOf":{"@id":"https:\/\/miranza.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#primaryimage"},"image":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#primaryimage"},"thumbnailUrl":"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg","datePublished":"2022-06-21T15:49:57+00:00","dateModified":"2024-10-30T15:18:37+00:00","description":"Expert ophthalmologists from Miranza are studying, in collaboration with Harvard University, future treatments for serious retinal pathologies.","breadcrumb":{"@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#primaryimage","url":"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg","contentUrl":"https:\/\/miranza.es\/wp-content\/uploads\/2022\/06\/miranza_doctores.jpg","width":740,"height":600,"caption":"miranza_doctores"},{"@type":"BreadcrumbList","@id":"https:\/\/miranza.es\/en\/news\/miranza-specialists-and-harvard-university-study-future-treatments-for-serious-retinal-pathologies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/miranza.es\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/miranza.es\/en\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Miranza Specialists and Harvard University Study Future Treatments for Serious Retinal Pathologies"}]},{"@type":"WebSite","@id":"https:\/\/miranza.es\/en\/#website","url":"https:\/\/miranza.es\/en\/","name":"Miranza","description":"Somos tus centros de excelencia, especialistas en bienestar ocular. Estamos a tu lado, creando nuevos horizontes para seguir viendo.","publisher":{"@id":"https:\/\/miranza.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/miranza.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/miranza.es\/en\/#organization","name":"Miranza","url":"https:\/\/miranza.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/miranza.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/miranza.es\/wp-content\/uploads\/2024\/04\/logo-miranza.jpg","contentUrl":"https:\/\/miranza.es\/wp-content\/uploads\/2024\/04\/logo-miranza.jpg","width":600,"height":600,"caption":"Miranza"},"image":{"@id":"https:\/\/miranza.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/GrupoMiranza\/","https:\/\/x.com\/GrupoMiranza","https:\/\/www.instagram.com\/grupomiranza\/","https:\/\/www.linkedin.com\/company\/grupomiranza","https:\/\/www.youtube.com\/channel\/UCX2gEI-gOFCbPHZ7QSTkLYQ\/featured"]},{"@type":"Person","@id":"https:\/\/miranza.es\/en\/#\/schema\/person\/e01c042f39bcd4da7bc9b77d6e23bf76","name":"Equipo Miranza","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/319e67a2c600de84615e0fdb3468ed425da29acb11edd895911d6403cf2975fd?s=96&d=mm&r=g","caption":"Equipo Miranza"}}]}},"_links":{"self":[{"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/posts\/43811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/comments?post=43811"}],"version-history":[{"count":2,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/posts\/43811\/revisions"}],"predecessor-version":[{"id":204033,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/posts\/43811\/revisions\/204033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/media\/43832"}],"wp:attachment":[{"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/media?parent=43811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/categories?post=43811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/miranza.es\/en\/wp-json\/wp\/v2\/tags?post=43811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}